Why the study?
The COVID-19 pandemic necessitated rethinking established protocols to optimize resources, prevent infection, and manage transfer times when considering cardiac catheterization.
Provides consensus guidance on optimizing resources and infection prevention during cardiac catheterization for ischemic and structural heart disease amid the COVID-19 pandemic.
Guides catheterization decisions to balance care and infection control during COVID-19; extends consensus to ischemic and structural interventions.
The current COVID-19 outbreak is forcing healthcare workers to continuously reconsider the proper indications for cardiac catheterization. Human and material resources optimization, infection prevention for patients and healthcare workers, and transfer times force a rethink of the previously established protocols. This article is a consensus statement of the Interventional Cardiology Association and the Ischemic Heart Disease Association of the Spanish Society of Cardiology, and aims to provide information to healthcare workers on the indications of diagnostic or therapeutic cardiac catheterization during the current COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Romaguera et al. (2020) conducted a review in Ischemic and structural heart disease during COVID-19. Cardiac catheterization protocols during COVID-19 was evaluated. A consensus statement from the Spanish Society of Cardiology provides guidance on the indications for diagnostic and therapeutic cardiac catheterization during the COVID-19 pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: